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Abstract
BACKGROUND: Uncoupling proteins (UCP) and β3-adrenergic receptor (ADRB3) gene polymorphism have been 
implicated in the susceptibility to type 2 diabetes mellitus (T2DM) but the results are inconsistent and inconclusive.
AIM: The aim was to investigate the relationship between -3826A/G (rs1800592) of UCP 1 and ADRB3 Trp64Arg 
(C/T) (rs4994) gene polymorphism and the incidence of T2DM among Saudis.
METHODS: Genotyping of both UCP1 and ADRB3 genes was carried out in 110 healthy controls and 108 unrelated 
Saudis with T2DM using polymerase chain reaction-based restriction fragment length polymorphism.
RESULTS: The genotype and allele frequencies of the UCP1 gene did not differ significantly between diabetic 
subjects and controls (p > 0.05). However, the CT genotype and the T allele of ADRB3 were higher in diabetic 
subjects compared with the controls while the CC genotype and C allele were higher in the controls relative to the 
diabetic subjects (Odds ratios [OR]: 7.85, 95% confidence interval [CI]: 4.23–14.59, p < 0.001 and OR: 7.434 95% 
CI: 4.026–13.39, p < 0.001, respectively).
CONCLUSION: The UCP1 -3826A/G polymorphism may not be associated with the susceptibility to T2DM among 
Saudis while T allele of ADRB3 may be related to the risk of T2DM, whereas the CC genotype and C allele may 
confer protection to T2DM.
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Introduction
In recent years, lifestyle-related diseases 
including type 2 diabetes mellitus (T2DM), obesity, 
and coronary artery disease have become a serious 
problem  [1]. These lifestyle-related diseases are thought 
to be related to both genetic and environmental factors [2]. 
Saudi-Arabian population is showing a steady increase 
in the prevalence of DM [3], [4]. DM is reported to be 
a potentially preventable disease if its risk factors are 
detected and lifestyle changes are implemented [5],  6], [7]. 
Among proteins that have a critical role in energy 
balance and metabolic regulation and in decreasing the 
mitochondrial production of reactive oxygen species, 
which are important mechanisms in the pathogenesis of 
obesity and/or T2DM, are the uncoupling proteins (UCPs) 
and Beta-3 adrenergic receptors [8], [9]. UCPs are 
transmembrane proteins which disrupt the proton gradient 
produced by oxidative phosphorylation by increasing 
the permeability of the inner mitochondrial membrane, 
allowing pumped protons into the intermembrane space 
to return to the mitochondrial matrix [8], [10], [11]. The 
UCP1 is mainly expressed in brown adipose tissue and 
acts as a proton transporter that uncouples oxidative 
reactions from ATP synthesis and energy consumption 
[12], [13]. Meanwhile, UCP1 acts in brown adipose 
tissue to generate heat by non-shivering thermogenesis 
which is the primary means of heat generation in human 
infants. Heat generation mediated by UCP1in brown fat 
uncouples the respiratory chain, leading to rapid substrate 
oxidation with a low rate of ATP production. Fatty acids 
activate UCP1 in the fat cell of brown adipose tissue 
while nucleotides inhibit it [11]. Fatty acids perform such 
activation through this cascade: Sympathetic nervous 
system (SNS) terminals release norepinephrine onto a 
Beta-3 adrenergic receptor on the plasma membrane. 
This activates adenylyl cyclase, which catalyzes the 
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conversion of ATP to cyclic AMP (cAMP). cAMP activates 
protein kinase A, causing its active C subunits to be freed 
from its regulatory R subunits. Active protein kinase A, 
in turn, phosphorylates triacylglycerol lipase, thereby 
activating it. The lipase converts triacylglycerols into free-
fatty acids, which activate UCP1, overriding the inhibition 
caused by purine nucleotides (guanosine diphosphate 
and adenosine diphosphate) [14], [15], [16]. At the 
termination of thermogenesis, the mitochondria oxidize 
away the residual fatty acids, UCP1 inactivates and the cell 
resumes its normal energy-conserving mode. A summary 
of this signaling pathway is shown in a schematic form 
(Figure 1). The relationship between the polymorphism of 
the UCP1 gene and the physical or metabolic variables 
has been previously studied in diverse ethnic populations 
[8], [17], [18]. UCP1 gene polymorphism especially the 
−3826A/G polymorphism in the promoter region has been 
investigated in several genetic studies which showed 
variable results. Some studies have shown that the 
−3826A/G polymorphism is associated with obesity, T2DM, 
body mass index (BMI), and other features of metabolic 
syndrome while other studies did not find any association 
between this polymorphism and these conditions [8], [19]. 
Meanwhile, it was reported that β 3-adrenergic receptors 
have a crucial role in thermogenesis and lipid tissue 
metabolism [20]. Mutation of the β3-adrenergic receptor 
(ADRB3) gene at codon 64 [Trp64Arg (C/T) (rs4994)] 
has been reported in different ethnic populations and was 
found to be associated with an early onset of T2DM and 
an increased weight gain and insulin resistance in specific 
populations [21], [22], [23], [24], [25]. Interestingly, it has 
been reported that both UCP1 and ADRB3 polymorphisms 
act synergistically to lower the basal metabolic rate and to 
decrease SNS activity [26], [27], [28]. Herein, we aimed 
to investigate whether the ADRB3 Trp64Arg (C/T) and 
UCP1 −3826A/G polymorphisms are associated with the 
risk of T2DM among Saudi population in Makkah region. 
To the best of our knowledge, this is the first report to 
study the association of ADRB3 Trp64Arg (C/T) and 
UCP1 -3826A/G polymorphisms and T2DM among Saudi 
population.
Materials and Methods
Study design and participants
A total of two hundreds eighteen gender- and 
age-matched Saudi participants were selected for the 
study. Hundred eight unrelated Saudi patients with 
T2DM were randomly recruited from the health centers 
and the teaching dental hospital, Faculty of Dentistry, 
Umm Al Qura University, Makkah region, Saudi Arabia. 
The control subjects consist of hundred ten healthy 
individuals who either attended a routine health check 
at a general practice or at their place at work. The 
inclusion criteria to select controls were the absence of 
family history of T2DM among parents, brothers, sisters, 
and siblings. All subjects were nonsmokers and non-
alcoholics. Patients with obesity, impaired renal function 
(diabetic nephropathy), and coronary artery disease were 
excluded. All subjects completed standard questionnaire 
and subjected to physical examination including basic 
data (name, age, gender, lifestyle [smoking, dietary 
intake, and physical activity], and anthropometric 
measures (height, weight, and BMI). Height and weight 
were measured while wearing light weight clothing 
and without shoes. The BMI was calculated from the 
equation: BMI = Weight (kg)/height(m2). Physical activity 
was assessed using physical activity questionnaire and 
the activity was divided into three levels (low, moderate, 
and high) (Table 1).
Table 1: Demographic and laboratory data for control subjects 
and patients with T2DM
Characteristics Control group Patient group p-value
(110) (108)
Age (years) 39.10 ± 6.07 41.2 ± 6.88 NS
Gender (M/F) 67/43 66/42
BMI (kg/m2) 23.47 ± 1.44 23.61 ± 1.23 NS
FBS 83.12 ± 7.13 159.19 ± 28.98 <0.001
HbA1c (%) 4.43 ± 1.03 7.23 ± 1.61 <0.05
Dietary intake (Vegetable intake) (%)
No or small 76 (69.09) 83 (76.85) NS
More 34 (30.91) 25 (23.15) NS
Physical activity (%)
Low 40 (36.36) 57 (52.78) <0.05
Moderate 22 (20) 32 (29.63) NS
High 48 (43.64) 19 (17.59) <0.001
Data are shown as mean ± SD. p < 0.05 was considered as significant. NS = Non-significant. T2DM: Type 
2 diabetes mellitus.
Figure 1: Beta-3 adrenergic receptor stimulation activates UCP1. 
This is carried out – at least in part – through activation of protein 
kinase A (PKA) and p38 mitogen-activated protein kinase (MAPK) 
pathway and inhibition of lysosomal pathways that degrade UCP1
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Ethics
This study was approved by the Ethics 
Review Board of the Faculty of Dentistry, Umm Al 
Qura University, Makkah, Saudi Arabia. All participants 
signed written informed consent before participation in 
the study.
Blood collection and biochemical 
procedures
Venous blood samples were obtained from all 
subjects after overnight fasting and each sample was 
divided into two halves, one half for serum preparation 
and the other half was put in sterile K3EDTA (tri-
potassium ethylenediaminetetraacetic acid) coated 
tubes. The buffy coat white cells were used for DNA 
extraction. The samples were kept at –20°C till the time of 
use. Fasting blood glucose (FBS) was determined using 
glucose oxidase method according to the manufacturer 
instructions (Human Diagnostics, Wiesbaden, Germany). 
HbA1c was quantitatively determined using enzymatic 
HbA1c assay kit according to the manufacturer instructions 
(Human Diagnostics, Wiesbaden, Germany).
Genomic DNA extraction
Peripheral blood leukocytes from the buffy coat 
of the anticoagulated blood were used for extraction of 
genomic DNA using DNA extraction kit (QIAamp DNA 
Blood Mini Kits, Qiagen, Hilden, Germany), according 
to the instructions of the manufacturer. Aliquots of 
genomic DNA were utilized for PCR amplification.
UCP1 genotyping
UCP1 −3826A/G polymorphism was 
determined using PCR-restriction fragment length 
polymorphism (RFLP) according to the method 
described previously [29]. The PCR was done in a final 
reaction volume of 20 µl using the primers: 5’-CTTGGG 
TAGTGACAAAGTAT-3’ as a forward primer and 5’- 
CCAAAGGGTCAGATTTCTAC-3’ as a reverse primer. 
PCR program consisted of starting step for 5 min at 
94°C; then 30 cycles at 94°C for 30 s, 55°C for 30 s, and 
72°C for 30 s; and a final incubation at 72°C for 10 min. 
The DNA product of PCR was cut with BclI restriction 
enzyme and separated on 3.0% agarose gel and 
then analyzed under ultraviolet (UV) light. Genotypes 
were identified according to the following pattern: 
G/G genotypes gave a single 470 bp band, while A/A 
genotype gave two bands of 250 bp and 220 bp.
ADRB3 Trp64Arg (C/T) genotyping
The genotyping of the ADRB3 Trp64Arg (C/T) 
polymorphism was determined by PCR-RFLP analysis 
as described before with slight modifications [22]. The 
PCR was done in a final reaction volume of 20 µl using 
primers: 5’-CGCCCAATACCGC CAACAC-3’ (upstream) 
and 5’-CCACCAGGAGTC CCATCACC-3’ (downstream), 
which flank the whole exon 1 of the ADRB3 gene. The 
PCR program consists of a starting step for 5 min at 94°C; 
then 35 cycles at 94°C for 30 s, 61°C for 30 s, and 72°C 
for 30 s and a final incubation step at 72°C by 10 min. 
Then, the amplified product of PCR was cut with MvaI 
restriction enzyme and then analyzed on a 3.0% agarose 
gel, and visualized under UV light. The TT genotype gave 
a single band of 161 base pairs; while the CC genotype 
gave two bands of 99 and 62 base pairs.
Clinical and laboratory data in wild type 
(CC) compared with CT plus TT genotypes
Table 1 shows clinical and laboratory data 
(FBS, BMI, HbA1c, vegetable intake, and physical 
activity) in CC genotype (wild type) compared with 
the CT plus TT genotypes of both control and T2DM 
subjects. Student t-test was used to compare the 
numerical data while Mann–Whitney U-test was used 
for comparison of ordinal data.
Statistical analysis
Data were analyzed using SPSS for Windows 
version 20.0 (SPSS Inc, Chicago. IL, USA). The 
analysis of the continuous variables in cases and 
controls was performed using Student t-test, whereas 
χ2 analysis was used to analyze the categorical data. 
Ordinal data were analyzed using the Mann–Whitney 
U-test. The difference between groups was considered 
statistically significant, if p < 0.05. Odds ratios (ORs) 
were calculated with 95% confidence interval (CI).
Results
Demographic, clinical, and laboratory data
The characteristics of the studied groups are 
shown in Table 1. Both control and T2DM groups were 
matched for age and gender. Regarding BMI, there was 
no significant difference between both groups. Fasting 
blood sugar and HbA1c were significantly higher in 
subjects with T2DM compared with the control group 
(p < 0.001 and < 0.05, respectively). The vegetable 
intake was higher, but not significant, in control group 
compared with T2DM group. Furthermore, comparison 
of physical activity between both groups showed that the 
physical activity (both low and moderate activity) was 
higher but not significant in T2DM subjects compared 
with the control group while high physical activity was 
significantly higher in control group compared with 
subjects with T2DM (p < 0.001).
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UCP 1 polymorphism
Table 2 shows the genotype and allele 
frequencies of the UCP1 gene polymorphism at the 
non-coding promoter region −3826A/G in both T2DM 
and control groups. The genotype distribution of UCP1 
polymorphism was in Hardy-Weinberg equilibrium in both 
the T2DM and control groups. The genotypes AA, AG, 
and GG were 50.91%, 40.91%, and 8.18%, respectively, 
in the control group and were 47.22%, 39.82%, and 
12.96%, respectively, in T2DM group. There was no 
significant difference in the genotype frequency between 
subjects with T2DM and healthy controls (p > 0.05) 
(Table 3). The percentage of G allele was 28.64% and 
32.87% while A allele was 71.36% and 67.13% in control 
and T2DM groups, respectively. There was no significant 
difference in the allele frequency between both T2DM 
subjects and healthy controls (p > 0.05) (Table 3). 
These results suggest that UCP1 A/G polymorphism 
at −3826 promoter region may not contribute to higher 
susceptibility to the T2DM in the Saudi population of 
Makkah region.
ADRB3 gene polymorphism
In contrast to the data for UCP1 gene 
polymorphism, our results for the ADRB3 revealed a 
different correlation. Table 3 shows the genotype and 
allele frequencies of ADRB3 Trp64Arg C/T (rs4994) in 
studied groups. The genotype and allele distribution 
were all in Hardy-Weinberg equilibrium in both studied 
groups. The genotypes CC, CT, and TT were 76.36%, 
20.91%, and 2.73% in control subjects, while they were 
30.56%, 65.74%, and 3.7% in subjects with T2DM, 
respectively. There was significant difference of CT 
genotypes between patients with T2DM and healthy 
controls and CC genotype (taken as a reference) 
seemed to be more protected while the CT genotypes 
are statistically higher in T2DM subjects compared with 
the controls (OR: 7.85, 95% CI: 4.23–14.59, p < 0.001) 
(Table 3). The C allele was 86.82% and 63.43% while T 
allele was 13.18% and 36.57% in the control and T2DM 
groups, respectively. The C allele (taken as a reference) 
was significantly higher in the control group than the 
patients with T2DM while the T allele was significantly 
higher in T2DM subjects compared with the control 
group (OR: 7.434, 95% CI: 4.026–13.39, p < 0.001) 
(Table 3). This suggests that CT genotype and subjects 
carrying the T allele have higher risk for T2DM than 
subjects with CC genotypes who may be protected.
Clinical and laboratory data in wild type 
(CC) compared with CT plus TT genotypes
Table 3 shows laboratory and clinical data 
of the CC (wild type) and the CT plus TT genotypes 
of both control and T2DM subjects. There was no 
significant difference between CC genotype and CT 
plus TT genotypes in both controls and T2DM subjects 
regarding fasting blood sugar, HbA1c, vegetable intake, 
and physical activity (both low and moderate) with 
the exception of the high physical activity which was 
significantly higher in CT plus TT genotypes compared 
with CC genotype in both controls and T2DM subjects 
(p < 0.01).
Table 3: Characteristics of different genotypes (CC compared 
with CT plus TT) of controls and subjects with T2DM
Characteristics ADRB3 (CC vs. CT plus TT)
CC CT plus TT p-value
Control
No 84 (76.36%) 26 (23.64)
FBS 83.92 ± 7.03 82.54 ± 6.96 NS
BMI 23.45 ± 1.57 23.53 ± 1.07 NS
HbA1c (%) 4.43 ± 1.00 4.43 ± 1.17 NS
Dietary intake (Vegetable intake)
No or small 58 (69.05) 18 (69.23) NS
More 26 (30.95) 8 (30.77) NS
Physical activity
Low 31 (36.90) 9 (34.61) NS
Moderate 19 (22.62) 3 (11.54) NS
High 34 (40.48) 14 (53.85) <0.01
T2DM
No. 33 (30.56%) 75 (69.44%)
FBS 158.95 ± 29.8 159.82 ± 28.44 NS
BMI 23.68 ± 1.1 23.49 ± 1.26 NS
HbA1c (%) 7.19 ± 1.67 7.27 ± 1.8 NS
Dietary intake (Vegetable intake)
No or small 27 (81.82%) 56 (74.67%)
More 6 (18.18%) 19 (25.33%) NS
Physical activity
Low 18 (54.55%) 39 (52%) NS
Moderate 11 (33.33%) 21 (28%) NS
High 4 (12.12%) 15 (20%) <0.01
Analysis of CC versus CT plus TT genotypes in both T2DM and healthy controls using Student t test in 
numerical data and Mann–Whitney U-test for ordinal data. Data are shown as mean ± SD. p < 0.05 was 
considered as significant. NS = Non-significant. ADRB3: β3-adrenergic receptor. T2DM: Type 2 diabetes 
mellitus.
Discussion
DM is a common public health problem 
worldwide including Saudi Arabia [4], [30]. UCP1 and 
ADRB3 play a pivotal role in energy expenditure in 
adipose tissue and the polymorphism in both genes 
may be associated with obesity, insulin resistance, 
and T2DM [8], [31]. We have investigated the gene 
polymorphism of both ADRB3 Trp64Arg (C/T) (rs4994) 
and UCP1 −3826A/G (rs1800592) and their association 
with the incidence of T2DM in a group of Saudi subjects. 
In the case of UCP1 gene, the AA genotype was found 
Table 2: Genotype distribution and allele frequencies of UCP1 
and ADRB3 polymorphisms in subjects with T2DM and control 
group
UCPI 
Polymorphism
Control (n = 110) T2DM (n = 108) p-value OR 95% CI
n % n %
UCPI polymorphism
Genotypes
AA 56 50.91 51 47.22 1
GA 45 40.91 43 39.82 0.886 1.049 0.597–1.845
GG 9 8.18 14 12.96 0.358 1.708 0.681–4.283
Alleles
A 157 71.36 145 67.13 1
G 63 28.64 71 32.87 0.591 1.159 0.681–1.97
ADRB3 polymorphism
Genotypes
CC 84 76.36 33 30.56 1
CT 23 20.91 71 65.74 <0.001  7.85 4.23–14.59
TT 3 2.73 4 3.7 0.19 3.39 0.72–15.99
Alleles
C 191 86.82 137 63.43 1
T 29 13.18 79 36.57 <0.001 7.434 4.026–13.39
Chi-square analysis of genotypes between patients with T2DM and healthy controls. p < 0.05 was 
considered as significant. ADRB3: β3-adrenergic receptor. T2DM: Type 2 diabetes mellitus, OR: Odds ratio, 
CI: Confidence interval.
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to be more common in studied Saudi subjects than GG 
genotype, but we did not find a significant difference 
in genotype and allele frequencies between the 
controls and the patients with T2DM (p > 0.05). Similar 
results were previously obtained in several ethnic 
populations [13], [27], [32], [33], [34], [35]. Therefore, 
our results are consistent with those results. Thus, we 
suggested that there may be no association between 
UCP1 polymorphism and the incidence of T2DM among 
Saudi subjects. However, other investigators obtained 
contrary result while studying UCP1 polymorphism 
among Brazilians with T2DM and they observed an 
association between UCP1 polymorphism and the risk 
of T2DM among obese Brazilians [19]. These opposite 
results might be explained by the difference in genetic 
background and exposure to environmental factors 
such as difference in ambient temperature range in a 
specific region. For ADRB3, our results showed that the 
CC genotype was significantly higher in controls than 
T2DM subjects while the CT genotype and T allele were 
significantly higher in T2DM subjects than controls. 
Therefore, T allele may be associated with the risk of 
T2DM among Saudis while CC genotype and C allele 
may be more protected. Similar results are obtained 
also in a number of ethnic populations. In Mexican 
population, Burguete-Garcia et al suggested that the T 
allele of ADRB3 gene can be considered an important 
risk factor for T2DM [31]. In Kashmiri population, it 
was reported that the T allele of the ADRB3 gene 
is a genotypic risk factor to T2DM, whereas the 
homozygous CC genotype exerted a protective effect 
[36]. These results are consistent with our observation. 
Other investigators have obtained differing results, 
for example, no association was detected between 
Trp64Arg (C/T) polymorphism of ADRB3 gene and 
the risk of T2DM in a number of ethnic populations 
(eastern Finland, Germans, young to older Japanese 
men, Polish population, and Caucasian-Brazilian 
patients) [37], [38], [39], [40], [41]. Examination of 
the secondary structure of ADRB3 using computer 
simulations suggests that the mutant residue Arginine 
at 64 position of the wild type Tryptophan may reside 
in the critical 36–64 amino acid peptide of the protein, 
that is, predicted to be “buried’ whereas amino acids 
65–66 (computed secondary structure, data not shown) 
are “exposed” to the aqueous side. This is followed by 
amino acid 67, that is, “buried,” and amino acids 68, 69 
are “exposed” and a sequence of 31 residues 70–100 
are “buried.” Thus, helical transmembrane region 38–63 
may be sensitive to a change from a highly hydrophobic 
tryptophan to highly charged polar amino acid Arginine 
(unpublished data of ADRB3 structural analysis). Since 
protein mobility in the membrane is related to changes 
in the temperature, environmental ambient temperature 
and energy metabolism may mediate receptor activity 
differently for the Arginine mutant Trp64Arg of the 
ADRB3.
The discrepancy between the above results 
and our observations may, among other possibilities, 
be clarified by differences in the genetic background 
of the participants or because of some intriguing 
environmental factors, such as temperature variations, 
may be physiologically important. One factor for 
consideration in our results on UCP1 and ADRB3 gene 
polymorphisms is that, this research has been made in 
Makkah environs of Saudi Arabia, an area that is known 
to have two seasonal variations, hot, and extremely hot. 
This is unlike many European nations, North America, 
and even areas in Asian countries that are situated 
in the northern hemisphere, and have significant cold 
seasons in addition to the hot and milder spells of 
temperature changes.
The limitation in this study is the small number 
of studied subjects. Further studies will be needed in a 
large T2DM cohort with clinical data to understand the 
role of UCP1 and ADRB3 gene polymorphisms in the 
pathogenesis of T2DM.
Conclusion
Our data showed that the UCP1 -3826A/G 
polymorphism in the promoter region did not result in 
statistically significant susceptibility to T2DM among 
Saudi population in Makkah region. In contrast, the T 
allele of ADRB3 gene polymorphism may be associated 
with the increased risk of T2DM. Interestingly, the CC 
genotypes in the ADRB3 gene appear to be more 
protective. Since genetic diversity plays a critical role in 
physiological outcome and phenotypes, it is important 
to note that genetic polymorphism studies may vary 
with different ethnic and environmental conditions.
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